Category: General

SFDA Approves Jascayd for Idiopathic Pulmonary Fibrosis Treatment

Riyadh:The Saudi Food and Drug Authority (SFDA) has approved the registration of Jascayd (nerandomilast) as a treatment for adult patients with idiopathic pulmonary fibrosis (IPF). This progressive lung disease is marked by the formation of fibrous sc…

KSrelief Team Evaluates Dialysis Center Operations in Yemen

Al-Mahra:A team from the King Salman Humanitarian Aid and Relief Center (KSrelief) inspected the progress on the fourth phase of the program to operate the dialysis center in Al-Mahra Governorate, Yemen.

According to Saudi Press Agency, the KSrelief…